Aerovate Therapeutics

+$0.34 (+2.75%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTE and other ETFs, options, and stocks.

About AVTE

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.

CEO
Timothy P. Noyes
Employees
16
Headquarters
Waltham, Massachusetts
Founded
2018

AVTE Key Statistics

Market cap
310.26M
Price-Earnings ratio
—
Dividend yield
—
Average volume
53.42K
High today
$13.00
Low today
$12.31
Open price
$12.37
Volume
42.68K
52 Week high
$29.43
52 Week low
$7.74

AVTE Earnings

-$23.80
-$15.89
-$7.98
-$0.07
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.28 per share
Actual
-$0.45 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure